Concepedia

Publication | Open Access

Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

42

Citations

17

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT03635567.

References

YearCitations

Page 1